 "Dr Lal PathLabs: Street worried over rising pressures")
Analysts expect Indian diagnostic firms to benefit from geographic expansions and price hikes.
Dr. Lal PathLabs, India’s biggest diagnostics firm by revenue, posted a bigger profit for the fourth straight quarter on Thursday, led by the addition of more labs and increased demand for medical tests.
The company’s consolidated net profit jumped 49% year-on-year to Rs 84.5 crore ($10.1 million) in the fourth quarter.
Its shares climbed as much as 7.8% after the results before trimming some gains to trade up about 6%. Rival Metropolis Healthcare was